XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Convertible Senior Notes, 1.375%
Cumulative Effect, Period of Adoption, Adjustment
[1]
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
[1]
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019       62,685,000        
Beginning balance at Dec. 31, 2019 $ 75.9   $ (1.1) $ 0.1 $ 749.0 $ (672.0) $ (1.1) $ (1.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       2,370,000        
Issuance of common stock 477.5       477.5      
Exercise of options to purchase common stock (in shares)       304,000        
Exercise of options to purchase common stock 11.3       11.3      
Issuance of shares for employee stock purchase plan (in shares)       19,000        
Issuance of shares for employee stock purchase plan 2.9       2.9      
Stock-based compensation expense 13.7       13.7      
Restricted stock units vested, net of shares withheld for taxes (in shares)       226,000        
Restricted stock units vested, net of shares withheld for taxes (26.8)       (26.8)      
Net (loss) income 12.3         12.3    
Other comprehensive income (loss) (2.4)             (2.4)
Ending balance (in shares) at Jun. 30, 2020       65,604,000        
Ending balance at Jun. 30, 2020 563.3     $ 0.1 1,227.6 (660.8)   (3.6)
Beginning balance (in shares) at Mar. 31, 2020       63,058,000        
Beginning balance at Mar. 31, 2020 59.0     $ 0.1 737.9 (675.2)   (3.8)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)       2,370,000        
Issuance of common stock 477.5       477.5      
Exercise of options to purchase common stock (in shares)       131,000        
Exercise of options to purchase common stock 5.1       5.1      
Issuance of shares for employee stock purchase plan (in shares)       19,000        
Issuance of shares for employee stock purchase plan 2.9       2.9      
Stock-based compensation expense 5.8       5.8      
Restricted stock units vested, net of shares withheld for taxes (in shares)       26,000        
Restricted stock units vested, net of shares withheld for taxes (1.6)       (1.6)      
Net (loss) income 14.4         14.4    
Other comprehensive income (loss) 0.2             0.2
Ending balance (in shares) at Jun. 30, 2020       65,604,000        
Ending balance at Jun. 30, 2020 $ 563.3     $ 0.1 1,227.6 (660.8)   (3.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Debt, interest rate   1.375%            
Beginning balance (in shares) at Dec. 31, 2020 66,017,444     66,017,000        
Beginning balance at Dec. 31, 2020 $ 603.6     $ 0.1 1,264.3 (666.3)   5.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of options to purchase common stock (in shares)       164,000        
Exercise of options to purchase common stock 6.2       6.2      
Issuance of shares for employee stock purchase plan (in shares)       17,000        
Issuance of shares for employee stock purchase plan 3.8       3.8      
Stock-based compensation expense 17.6       17.6      
Restricted stock units vested, net of shares withheld for taxes (in shares)       170,000        
Restricted stock units vested, net of shares withheld for taxes (27.3)       (27.3)      
Extinguishment of conversion feature, net of issuance costs (737.7)       (737.7)      
Issuance of shares for debt repayment (in shares)       2,242,000        
Issuance of shares for debt repayment 622.7       622.7      
Net (loss) income (25.0)         (25.0)    
Other comprehensive income (loss) $ (4.8)             (4.8)
Ending balance (in shares) at Jun. 30, 2021 68,610,078     68,610,000        
Ending balance at Jun. 30, 2021 $ 459.1     $ 0.1 1,149.6 (691.3)   0.7
Beginning balance (in shares) at Mar. 31, 2021       66,213,000        
Beginning balance at Mar. 31, 2021 585.3     $ 0.1 1,248.3 (666.3)   3.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of options to purchase common stock (in shares)       121,000        
Exercise of options to purchase common stock 4.7       4.7      
Issuance of shares for employee stock purchase plan (in shares)       17,000        
Issuance of shares for employee stock purchase plan 3.8       3.8      
Stock-based compensation expense 9.0       9.0      
Restricted stock units vested, net of shares withheld for taxes (in shares)       17,000        
Restricted stock units vested, net of shares withheld for taxes (1.2)       (1.2)      
Extinguishment of conversion feature, net of issuance costs (737.7)       (737.7)      
Issuance of shares for debt repayment (in shares)       2,242,000        
Issuance of shares for debt repayment 622.7       622.7     0.0
Net (loss) income (25.0)         (25.0)    
Other comprehensive income (loss) $ (2.5)             (2.5)
Ending balance (in shares) at Jun. 30, 2021 68,610,078     68,610,000        
Ending balance at Jun. 30, 2021 $ 459.1     $ 0.1 $ 1,149.6 $ (691.3)   $ 0.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Debt, interest rate   1.375%            
[1] The Company recorded a cumulative effect adjustment to retained earnings to reflect the adoption of Accounting Standards Update 2016-13, Credit Losses (Topic 326). Refer to Note 2 of Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2020.